Skip to main content

Table 2 HPV and HIV-co-infection at 3 anatomical sites among MSM in Cape Town, South Africa

From: The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in Cape Town, South Africa

HPV type classification ANAL (n = 191) ORO-PHARYNGEAL (n = 200) URINE (n = 190)
Total (%) HIV- (n = 106) HIV+ (n = 85) P-value Total (%) HIV- (n = 112) HIV+ (n = 88) P-value Total (%) HIV- (n = 107) HIV+ (n = 83) P-value
No type 52 (27.2) 45 (42.4) 7 (8.2) ˂0.001 177 (88.5) 104 (92.9) 73 (83.0) 0.029 161 (84.7) 91 (85.1) 70 (84.3) 0.892
Any type 139 (72.8) 61 (57.6) 78 (91.8) ˂0.001 23 (11.5) 8 (7.1) 15 (17.1) 0.029 29 (15.3) 16 (14.3) 13 (14.8) 0.892
Single type 26 (13.6) 21 (19.8) 5 (5.9) 0.005 16 (8.0) 6 (5.4) 10 (11.4) 0.120 22 (11.6) 14 (12.5) 8 (9.1) 0.461
Multiple types 113 (59.2) 40 (37.7) 73 (85.9) ˂0.001 7 (3.5) 2 (1.8) 5 (5.7) 0.136 7 (3.7) 2 (1.8) 5 (5.7) 0.131
LR-HPV 126 (66.0) 50 (47.2) 76 (89.4) ˂0.001 14 (7.0) 4 (3.6) 10 (11.4) 0.032 19 (10.0) 8 (7.5) 11 (13.3) 0.188
HR-HPV 110 (57.6) 41 (38.7) 69 (81.2) ˂0.001 15 (7.5) 6 (5.4) 9 (10.2) 0.194 15 (7.9) 9 (8.4) 6 (7.2) 0.764
HPV-6/11 50 (26.2) 19 (17.9) 31 (36.5) 0.003 3 (1.5) 1 (0.9) 2 (2.3) 0.425 3 (1.6) 0 (0.0) 3 (3.6) 0.047
HPV-16/18 55 (28.8) 19 (17.9) 36 (42.4) ˂0.001 6 (3.0) 3 (2.7) 3 (3.4) 0.763 3 (1.6) 2 (1.9) 1 (1.2) 0.715
HPV-6/11/16/18 77 (40.3) 30 (28.3) 47 (55.3) ˂0.001 9 (4.5) 4 (3.6) 5 (5.7) 0.474 6 (3.2) 2 (1.9) 4 (4.8) 0.248
HPV-31/33/45 50 (26.2) 14 (13.2) 36 (42.4) ˂0.001 3 (1.5) 0 (0.0) 3 (3.4) 0.048 5 (2.6) 3 (2.8) 2 (2.4) 0.866
HPV-6/11/16/18/31/33/45 98 (51.3) 36 (34.0) 62 (72.9) ˂0.001 11 (5.5) 4 (3.6) 7 (8.0) 0.177 10 (5.3) 5 (4.7) 5 (6.0) 0.679